Fig. 3.

Microvesicle counts of patients with soft tissue with and without a history of venous thromboembolism (VTE). Comparison of G2 soft tissue sarcoma patients with and without positive history of VTE, M1 soft tissue sarcoma patients with and without positive history of VTE and all soft tissue sarcoma patients with and without a positive history of VTE. G1 and G3 soft tissue sarcoma patients did not exhibit a positive history of VTE. Data are presented as mean value ± standard deviation (SD). p-values were determined using Student’s t-tests for independent samples. a. Annexin V = total amount of microvesicles as detected using FACS. b. CD45 (leukocyte common antigen) = leukocyte-derived microvesicles. c. CD61 (Integrin β3) = platelet-derived microvesicles. d. CD62P (P-selectin) = activated platelet-derived microvesicles. e. CD63 (gp55) = activated platelet-derived microvesicles. f. CD62E (E-selectin) = endothelium-derived microvesicles. g. CD142 (Tissue Factor) = microvesicles carrying tissue factor